Aquilo Capital Management, LLC Blueprint Medicines Corp Transaction History

Aquilo Capital Management, LLC

$128 Million
Q3 2024

A detailed history of Aquilo Capital Management, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Aquilo Capital Management, LLC holds 124,600 shares of BPMC stock, worth $11.3 Million. This represents 8.97% of its overall portfolio holdings.

Number of Shares

124,600

Previous 114,600 8.73%

Holding current value

$11.3 Million

Previous $12.4 Million 6.73%

% of portfolio

8.97%

Previous 12.35%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$84.1 - $120.5 $841,000 - $1.21 Million	10,000 Added 8.73%	124,600 $11.5 Million
Q2 2024 Aug 14, 2024	SELL	$85.18 - $108.78 $5.75 Million - $7.35 Million	-67,551 Reduced 37.09%	114,600 $12.4 Million
Q1 2024 May 15, 2024	SELL	$73.17 - $99.79 $5.32 Million - $7.25 Million	-72,676 Reduced 28.52%	182,151 $17.3 Million
Q4 2023 Feb 14, 2024	SELL	$43.96 - $92.84 $5.46 Million - $11.5 Million	-124,263 Reduced 32.78%	254,827 $23.5 Million
Q3 2023 Nov 14, 2023	SELL	$46.9 - $66.0 $3.28 Million - $4.61 Million	-69,897 Reduced 15.57%	379,090 $19 Million
Q2 2023 Aug 14, 2023	SELL	$42.2 - $66.37 $7.34 Million - $11.5 Million	-173,842 Reduced 27.91%	448,987 $28.4 Million
Q1 2023 May 15, 2023	BUY	$37.97 - $50.0 $1.56 Million - $2.05 Million	41,061 Added 7.06%	622,829 $28 Million
Q4 2022 Feb 14, 2023	BUY	$41.06 - $66.48 $2.36 Million - $3.82 Million	57,500 Added 10.97%	581,768 $25.5 Million
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $9.6 Million - $14.9 Million	-192,271 Reduced 26.83%	524,268 $34.5 Million
Q2 2022 Aug 15, 2022	SELL	$45.23 - $70.15 $2.94 Million - $4.56 Million	-65,000 Reduced 8.32%	716,539 $36.2 Million
Q1 2022 May 16, 2022	BUY	$54.1 - $110.08 $7.36 Million - $15 Million	136,000 Added 21.07%	781,539 $49.9 Million
Q4 2021 Feb 14, 2022	BUY	$94.25 - $115.99 $11.7 Million - $14.4 Million	123,866 Added 23.74%	645,539 $69.1 Million
Q3 2021 Nov 15, 2021	BUY	$80.98 - $109.47 $5.92 Million - $8.01 Million	73,161 Added 16.31%	521,673 $53.6 Million
Q2 2021 Aug 16, 2021	BUY	$82.78 - $101.0 $2.11 Million - $2.58 Million	25,500 Added 6.03%	448,512 $39.5 Million
Q1 2021 May 17, 2021	BUY	$90.71 - $108.28 $3.9 Million - $4.66 Million	43,000 Added 11.32%	423,012 $41.1 Million
Q4 2020 Feb 16, 2021	SELL	$92.08 - $124.48 $526,237 - $711,403	-5,715 Reduced 1.48%	380,012 $42.6 Million
Q3 2020 Nov 16, 2020	BUY	$66.45 - $92.7 $4.7 Million - $6.55 Million	70,698 Added 22.44%	385,727 $35.8 Million
Q2 2020 Aug 14, 2020	BUY	$57.09 - $79.27 $18 Million - $25 Million	315,029 New	315,029 $24.6 Million
Q2 2019 Aug 14, 2019	SELL	$73.54 - $97.8 $2.25 Million - $2.99 Million	-30,618 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$48.7 - $86.6 $1.49 Million - $2.65 Million	30,618 New	30,618 $2.45 Million

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquilo Capital Management, LLC with notifications on news.

Account

Aquilo Capital Management, LLC Blueprint Medicines Corp Transaction History